Tumor markers in the recognition and management of poorly differentiated neoplasms and cancers of unknown primary.
D000135:Acid Phosphatase / Q000032:analysis; D000243:Adenosine Deaminase / Q000032:analysis; D000469:Alkaline Phosphatase / Q000032:analysis; D006631:Amine Oxidase (Copper-Containing) / Q000032:analysis; D000626:Aminopeptidases / Q000032:analysis; D000951:Antigens, Neoplasm / Q000032:analysis*; D002272:Carcinoembryonic Antigen / Q000032:analysis; D003402:Creatine Kinase / Q000032:analysis; D004254:DNA Nucleotidyltransferases / Q000032:analysis; D004798:Enzymes / Q000032:analysis*; D005634:Fructose-Bisphosphate Aldolase / Q000032:analysis; D006729:Hormones, Ectopic / Q000032:analysis*; D006801:Humans; D007770:L-Lactate Dehydrogenase / Q000032:analysis; D009369:Neoplasms / Q000175:diagnosis*; D000509:alpha-Fetoproteins / Q000032:analysis
D000951:Antigens, Neoplasm; D002272:Carcinoembryonic Antigen; D004798:Enzymes; D006729:Hormones, Ectopic; D000509:alpha-Fetoproteins; D007770:L-Lactate Dehydrogenase; D006631:Amine Oxidase (Copper-Containing); D003402:Creatine Kinase; D004254:DNA Nucleotidyltransferases; D000469:Alkaline Phosphatase; D000135:Acid Phosphatase; D000626:Aminopeptidases; D000243:Adenosine Deaminase; D005634:Fructose-Bisphosphate Aldolase